SCHEMBL23366242

SCHEMBL23366242

NC(CC(=O)NCS(=O)(=O)O)C(=O)NC(CC(=O)NCS(=O)(=O)O)C(=O)NC(CC(=O)NCS(=O)(=O)O)C(=O)NCS(=O)(=O)O

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 2/20 0.34
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23366225 0.85 DPP7 (0.33) FPR2
SCHEMBL18882378 0.75 GRIK1 (0.39)
SCHEMBL23366240 0.74 ENPEP (0.40) PTPN1
SCHEMBL23366203 0.74 ENPEP (0.40) PTPN1
SCHEMBL23366206 0.74 ENPEP (0.40) PTPN1
SCHEMBL24180291 0.71 FPR2 (0.31) FPR2
SCHEMBL18877671 0.70 TP53 (0.34) FPR2
SCHEMBL23366241 0.68 ECE1 (0.42) PTPN1
SCHEMBL18882380 0.68 DPP7 (0.35) FPR2
SCHEMBL23366214 0.67 CA2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11007274-B2 Compounds for medicinal applications AusVir Therapeutics Pty Ltd (AU) 2021-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11007274-B2 Compounds for medicinal applications HAVCR2, ENGASE, DNPEP FPR2 2914/4885PTPN1 2458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.